Resources for Correctional and Detention Facilities Preparing for the Release of People with Substance Use Disorder during COVID-19 [02/08/2022]
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

For very narrow results

When looking for a specific result

Best used for discovery & interchangable words

Recommended to be used in conjunction with other fields

Dates

to

Document Data
Library
People
Clear All
Clear All

For additional assistance using the Custom Query please check out our Help Page

CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners. As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
i

i

Up-to-date Information

Up-to-Date Info: To find the latest CDC information on this topic go to: https://www.cdc.gov/coronavirus/2019-nCoV/index.html

Resources for Correctional and Detention Facilities Preparing for the Release of People with Substance Use Disorder during COVID-19 [02/08/2022]

Filetype[PDF-100.90 KB]


English

Details:

  • Corporate Authors:
  • Description:
    Linking people with substance use disorder (SUD) to care and treatment as they return to their communities is an important consideration for correctional and detention facilities during the COVID-19 pandemic. Many studies report that the time following release from a correctional facility is an especially common time for fatal drug overdoses, particularly from opioids.

    Access to care and treatment, including access to medications for opioid use disorder (MOUD) and provision of naloxone, an opioid overdose reversal drug, can help ensure the safety of those released.3 Research shows that providing people leaving prisons or jails buprenorphine or methadone is associated with decreases in overdose deaths in the immediate weeks after release.

    Access to care and treatment is more critical than ever as the number of overdose deaths in the United States is increasing. Early data suggest that overdose deaths increased 31% for the 12 months ending in January 2021 compared to the previous year. Access to care and treatment will depend on locally available programs and resources.

    CS 327180-B 02/08/2022

    Resources-for-Reentry-SUD-Final-508.pdf

  • Subjects:
  • Collection(s):
  • Main Document Checksum:
  • Download URL:
  • File Type:

Supporting Files

  • No Additional Files
More +

You May Also Like

Checkout today's featured content at stacks.cdc.gov